Smith DC, et al. Clin. Cancer Res. (2014) cited as Ref 595 in DOI: 10.1038/s41392-020-0110-5 (Q9858)

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Smith DC, et al. Clin. Cancer Res. (2014) cited as Ref 595 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Smith DC
    0 references
    0 references
    2014
    0 references
    Clin. Cancer Res.
    0 references
    20
    0 references
    A phase I dose escalation and expansion study of the anticancer stem cell agent demcizumab (anti-DLL4) in patients with previously treated solid tumors (English)
    0 references
    6295-6303
    0 references